ArticleThe Canadian journal of urology2026
Optimizing postoperative pain relief with a novel technique: intraluminal lidocaine administration during retrograde intrarenal surgery.
Article in The Canadian journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesRetrograde intrarenal surgery (RIRS) has become an increasingly preferred minimally invasive option for the management of kidney stones. However, postoperative pain remains a major clinical concern that may adversely affect patient comfort and recovery. This study aimed to evaluate whether intraluminal administration of lidocaine at the end of RIRS could effectively reduce postoperative pain and analgesic requirements.
methodsA total of 61 patients who underwent RIRS between March and July 2024 were evaluated. Four patients were excluded due to residual stones, and five due to a history of cardiac arrhythmia, leaving 52 patients for analysis. Patients were divided into two groups according to the use of intraluminal lidocaine: Group L (Lidocaine Group, n = 27) received 100 mg of lidocaine prior to DJ stent placement, whereas Group C (Control Group, n = 25) did not. Demographic and stone-related parameters were recorded. Postoperative pain was assessed using the Visual Analog Scale (VAS) at 1, 4, 8, 12, and 24 h, and postoperative analgesic use was documented.
resultsNo significant differences were observed between the groups regarding demographic characteristics, stone parameters, or preoperative pain scores. However, postoperative VAS scores were significantly lower in Group L at the 8th and 12th hours (p = 0.041 and p = 0.028, respectively). Moreover, total postoperative analgesic consumption was significantly lower in Group L (p = 0.027), supporting the analgesic efficacy of intraluminal lidocaine administration.
conclusionIntraluminal lidocaine administration at the end of RIRS appears to be a safe, feasible, and effective method for reducing postoperative pain and minimizing analgesic requirements. These findings suggest that the technique may contribute to improved postoperative recovery, although larger multicenter studies are warranted to confirm its clinical value.
Indexed as
Identifiers
42415584What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.